KIMBERLY HAYES: Open Payments
NPI 1467448878 · VERNON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$2,636 in 135 payments from 32 companies in 2025. Trend: 2023 $2,882 · 2024 $3,031 · 2025 $2,636
Food & beverage: $2,601Education: $36
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 38 | $683 |
| Vanda Pharmaceuticals Inc. | 11 | $202 |
| ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | 11 | $199 |
| AstraZeneca Pharmaceuticals LP | 7 | $147 |
| Otsuka America Pharmaceutical, Inc. | 7 | $145 |
| Amgen Inc. | 6 | $121 |
| Exact Sciences Corporation | 5 | $116 |
| Lilly USA, LLC | 5 | $101 |
| Lundbeck LLC | 5 | $89 |
| GlaxoSmithKline, LLC. | 3 | $76 |
Products named: VRAYLAR, REXULTI, QULIPTA, FANAPT, CAPLYTA, UBRELVY, Cologuard Collection Kit, AIRSUPRA.
Industry payments across CT — which companies pay providers there.
